Citation Impact
Citing Papers
Reciprocal Regulation of DUSP9 and DUSP16 Expression by HIF1 Controls ERK and p38 MAP Kinase Activity and Mediates Chemotherapy-Induced Breast Cancer Stem Cell Enrichment
2018 StandoutNobel
Cancer statistics, 2022
2022 Standout
Associations Among Antimicrobial Use and Antimicrobial Resistance of Salmonella spp. Isolates from 60 Alberta Finishing Swine Farms
2008
Whole-genome resequencing reveals loci under selection during chicken domestication
2010 StandoutNature
Cancer Statistics, 2021
2021 Standout
The re-emergence of natural products for drug discovery in the genomics era
2015 Standout
Bovine Mastitis: An Evolving Disease
2002 Standout
Bioactive Natural Products from Papua New Guinea Marine Sponges
2012
Molecular mechanisms of antibiotic resistance
2014 Standout
Mouse model of X–linked chronic granulomatous disease, an inherited defect in phagocyte superoxide production
1995
A Deletion of the Paracellin-1 Gene Is Responsible for Renal Tubular Dysplasia in Cattle
2000
A comprehensive map of molecular drug targets
2016 Standout
Neutrophils at work
2014 Standout
The biology and management of non-small cell lung cancer
2018 StandoutNature
Pan-European resistance monitoring programmes encompassing food-borne bacteria and target pathogens of food-producing and companion animals
2013
Leukocyte adhesion deficiencies
2012
Influence of Clinical Mastitis During Early Lactation on Reproductive Performance of Jersey Cows
1998
Marine natural products
1990 Standout
Defensins: antimicrobial peptides of innate immunity
2003 Standout
Marine natural products
2011
Physical and Functional Association of LFA-1 with DNAM-1 Adhesion Molecule
1999
Classification and mutation prediction from non–small cell lung cancer histopathology images using deep learning
2018 Standout
Life in cellulose houses: symbiotic bacterial biosynthesis of ascidian drugs and drug leads
2010
Drug development from marine natural products
2008 Standout
Physiology of Mastitis and Factors Affecting Somatic Cell Counts
1994 Standout
The Advantages of Targeted Protein Degradation Over Inhibition: An RTK Case Study
2017
A Stochastic Assessment of the Public Health Risks of the Use of Macrolide Antibiotics in Food Animals
2008
Stochastic Modeling to Determine the Economic Effects of Blanket, Selective, and No Dry Cow Therapy
2007
Bendigoles D–F, bioactive sterols from the marine sponge-derived Actinomadura sp. SBMs009
2011
Mapping genes for complex traits in domestic animals and their use in breeding programmes
2009
Hepatocellular carcinoma
2021 Standout
Silica crystals and aluminum salts activate the NALP3 inflammasome through phagosomal destabilization
2008 Standout
Cytokine regulation of cellular adhesion molecule expression in inflammation
1999
Bio-mining the microbial treasures of the ocean: New natural products
2011
Different strategies to overcome multidrug resistance in cancer
2013
Cumulative Physiological Events Influence the Inflammatory Response of the Bovine Udder to Escherichia coli Infections During the Transition Period
2007
The NOX Family of ROS-Generating NADPH Oxidases: Physiology and Pathophysiology
2007 Standout
Lung cancer: current therapies and new targeted treatments
2016 Standout
Highlights of marine invertebrate-derived biosynthetic products: Their biomedical potential and possible production by microbial associants
2011
Evaluation of Udder Preparations on Intramammary Infections
1988
Allergic Rhinitis and Its Impact on Asthma
2001 Standout
Genetic analysis of integrin function in man: LAD-1 and other syndromes
2000
Genetic dissection of phenotypic diversity in farm animals
2001
From the Sea to Anticancer Therapy
2011
Cytotoxic chemotherapy: Still the mainstay of clinical practice for all subtypes metastatic breast cancer
2016
Marine organisms as a therapeutic source against herpes simplex virus infection
2011
Eribulin monotherapy versus treatment of physician's choice in patients with metastatic breast cancer (EMBRACE): a phase 3 open-label randomised study
2011
Activity of eribulin mesylate in patients with soft-tissue sarcoma: a phase 2 study in four independent histological subtypes
2011
How were new medicines discovered?
2011 Standout
Accessing the Hidden Majority of Marine Natural Products through Metagenomics
2011
Variation in Tropical Reef Symbiont Metagenomes Defined by Secondary Metabolism
2011
Outcomes Based on Plasma Biomarkers for the Phase 3 CELESTIAL Trial of Cabozantinib versus Placebo in Advanced Hepatocellular Carcinoma
2021
Common SNPs explain a large proportion of the heritability for human height
2010 Standout
High-Resolution Microtubule Structures Reveal the Structural Transitions in αβ-Tubulin upon GTP Hydrolysis
2014 StandoutNobel
Microtubule-binding agents: a dynamic field of cancer therapeutics
2010 Standout
PROTAC targeted protein degraders: the past is prologue
2022 Standout
Call of the wild: antibiotic resistance genes in natural environments
2010 Standout
Strategies and challenges for the next generation of antibody–drug conjugates
2017 Standout
Tackling antibiotic resistance: the environmental framework
2015 Standout
A 100-Year Review: Mastitis detection, management, and prevention
2017 Standout
Drug Discovery from Marine Microbes
2012
The immunology of hepatocellular carcinoma
2018
Severity of E. coli mastitis is mainly determined by cow factors
2003
Dabrafenib in patients with BRAFV600E-positive advanced non-small-cell lung cancer: a single-arm, multicentre, open-label, phase 2 trial
2016
Getting to the site of inflammation: the leukocyte adhesion cascade updated
2007 Standout
Gold from the sea: Marine compounds as inhibitors of the hallmarks of cancer
2011
Integrins
2002 Standout
Premilking Udder Hygiene
1989
Lessons from the Past and Charting the Future of Marine Natural Products Drug Discovery and Chemical Biology
2012
Engineered Nanoparticles for Drug Delivery in Cancer Therapy
2014 Standout
Endogenous Antimicrobial Peptides and Skin Infections in Atopic Dermatitis
2002 Standout
Eribulin versus dacarbazine in previously treated patients with advanced liposarcoma or leiomyosarcoma: a randomised, open-label, multicentre, phase 3 trial
2016 Standout
Diving for drugs: tunicate anticancer compounds
2012
Beyond EGFR and ALK inhibition: Unravelling and exploiting novel genetic alterations in advanced non small-cell lung cancer
2015
Hepatocellular carcinoma
2022 Standout
Correlation between veterinary antimicrobial use and antimicrobial resistance in food-producing animals: a report on seven countries
2013
Immediate and carryover effects of Gram-negative and Gram-positive toxin-induced mastitis on follicular function in dairy cows
2011
The expanding role of marine microbes in pharmaceutical development
2010
Analytical techniques for discovery of bioactive compounds from marine fungi
2012
NK CELL RECOGNITION
2004 Standout
Marketed Marine Natural Products in the Pharmaceutical and Cosmeceutical Industries: Tips for Success
2014
Identification of a Novel Genomic Island Conferring Resistance to Multiple Aminoglycoside Antibiotics in Campylobacter coli
2012
First Natural Analogs of the Cytotoxic Thiodepsipeptide Thiocoraline A from a Marine Verrucosispora sp.
2011
Initial testing (stage 1) of eribulin, a novel tubulin binding agent, by the pediatric preclinical testing program
2013
Epithelial antibiotic induced in states of disease
1997
Drug Discovery and Natural Products: End of an Era or an Endless Frontier?
2009 StandoutScience
Global trends in antimicrobial use in food animals
2015 Standout
The Src Family Kinases Hck and Fgr Are Dispensable for Inside-Out, Chemoattractant-Induced Signaling Regulating β2 Integrin Affinity and Valency in Neutrophils, but Are Required for β2 Integrin-Mediated Outside-In Signaling Involved in Sustained Adhesion
2006
Cyclopeptides and polyketides from coral-associated fungus, Aspergillus versicolor LCJ-5-4
2011
Eribulin mesylate: A novel halichondrin B analogue for the treatment of metastatic breast cancer
2012
Marine Natural Products: A New Wave of Drugs?
2011
MET As a Possible Target for Non–Small-Cell Lung Cancer
2013
Mitochondrial DNA and the origins of the domestic horse
2002 Standout
Impact of β2 integrin deficiency on mouse natural killer cell development and function
2011 StandoutNobel
High prevalence of antimicrobial-resistant genes and integrons in Escherichia coli isolates from Black-headed Gulls in the Czech Republic
2007
Targeted therapies for treatment of non‐small cell lung cancer—Recent advances and future perspectives
2015
Spontaneous Skin Ulceration and Defective T Cell Function in CD18 Null Mice
1998
Aetiology of clinical mastitis in six Somerset dairy herds
2001
Phase III Open-Label Randomized Study of Eribulin Mesylate Versus Capecitabine in Patients With Locally Advanced or Metastatic Breast Cancer Previously Treated With an Anthracycline and a Taxane
2015
Alkaloids from the Sponge‐Associated Fungus Aspergillus sp.
2012
Bioprospecting for bioactives from seaweeds: potential, obstacles and alternatives
2012
A Historical Overview of Natural Products in Drug Discovery
2012 Standout
Discovery and Synthesis of Namalide Reveals a New Anabaenopeptin Scaffold and Peptidase Inhibitor
2011
Diverse and abundant antibiotic resistance genes in Chinese swine farms
2013 Standout
Marine Antitumor Drugs: Status, Shortfalls and Strategies
2010
β-Defensins: Linking Innate and Adaptive Immunity Through Dendritic and T Cell CCR6
1999 StandoutScience
Food Animals and Antimicrobials: Impacts on Human Health
2011 Standout
Field Trial Evaluation of Premilking Teat Disinfection
1987
Immense Essence of Excellence: Marine Microbial Bioactive Compounds
2010
Antinociceptive and Anti-Inflammatory Activities of Crude Methanolic Extract of Red Alga Bryothamnion triquetrum
2012
Eribulin Binds at Microtubule Ends to a Single Site on Tubulin To Suppress Dynamic Instability
2009
Olaparib Monotherapy in Patients With Advanced Cancer and a Germline BRCA1/2 Mutation
2014 Standout
Claudins and the Modulation of Tight Junction Permeability
2013 Standout
Emerging Targets in Photopharmacology
2016 StandoutNobel
Osteosarcoma: Current Treatment and a Collaborative Pathway to Success
2015 Standout
Haemopoietic chimaerism: a complication in heterozygote detection tests for inherited defects in cattle
1994
Phylogenetic Perspectives in Innate Immunity
1999 StandoutScienceNobel
Free Radicals in the Physiological Control of Cell Function
2002 Standout
Targeted therapy for non-small cell lung cancer: current standards and the promise of the future.
2015
New Quinazolinone Alkaloids within Rare Amino Acid Residue from Coral-Associated Fungus, Aspergillus versicolor LCJ-5-4
2011
4-Acetoxydolastane Diterpene from the Brazilian Brown Alga Canistrocarpus cervicornis as Antileishmanial Agent
2011
Antiviral Lead Compounds from Marine Sponges
2010
Works of Dale E. Shuster being referenced
A Phase I Study of Eribulin Mesylate (E7389), a Mechanistically Novel Inhibitor of Microtubule Dynamics, in Patients with Advanced Solid Malignancies
2009
Phase I Study of Eribulin Mesylate Administered Once Every 21 Days in Patients with Advanced Solid Tumors
2009
Cytokine production during endotoxin-induced mastitis in lactating dairy cows
1993
The odyssey of marine pharmaceuticals: a current pipeline perspective
2010
Physiological Responses to Intramammary or Intravenous Treatment with Endotoxin in Lactating Dairy Cows
1990
High Cortisol Concentrations and Mediation of the Hypogalactia During Endotoxin-Induced Mastitis
1992
A European survey of antimicrobial susceptibility among zoonotic and commensal bacteria isolated from food-producing animals
2004
Efficacy of Recombinant Bovine Interleukin-2 as an Adjunct to Dry Cow Therapy
1995
Suppression of Milk Production During Endotoxin-Induced Mastitis
1991
Relationship of Inflammatory Cytokines, Growth Hormone, and Insulin-Like Growth Factor-I to Reduced Performance During Infectious Disease
1995
Administration of recombinant human interleukin 1 receptor antagonist during endotoxin-induced mastitis in cows
1995
Bacterial growth, inflammatory cytokine production, and neutrophil recruitment during coliform mastitis in cows within ten days after calving, compared with cows at midlactation
1996
Bacterial growth, inflammatory cytokine production, and neutrophil recruitment during coliform mastitis in cows within ten days after calving, compared with cows at midlactation.
1996
Complement fragment C5a and inflammatory cytokines in neutrophil recruitment during intramammary infection with Escherichia coli
1997
Bovine leukocyte adhesion deficiency. Beta 2 integrin deficiency in young Holstein cattle.
1992
Phase II study of eribulin mesylate (E7389) in patients (pts) with locally advanced or metastatic breast cancer (MBC) previously treated with anthracycline, taxane, and capecitabine therapy
2008
Tumor and circulating biomarkers in patients with second-line hepatocellular carcinoma from the randomized phase II study with tivantinib
2016
Prognostic value of the neutrophil-to-lymphocyte ratio in the ARQ 197-215 second-line study for advanced hepatocellular carcinoma
2017
Phase II Study of Eribulin Mesylate, a Halichondrin B Analog, in Patients With Metastatic Breast Cancer Previously Treated With an Anthracycline and a Taxane
2009
Efficacy Analysis for Molecular Subgroups in MARQUEE: a Randomized, Double-blind, Placebo-controlled, Phase 3 Trial of Tivantinib (ARQ 197) Plus Erlotinib versus Placebo plus Erlotinib in Previously Treated Patients with Locally Advanced or Metastatic, Non-squamous, Non-small Cell Lung Cancer (NSCLC)
2014
Identification and prevalence of a genetic defect that causes leukocyte adhesion deficiency in Holstein cattle.
1992
Effects of Premilking Udder Preparation on Bacterial Population, Sediment, and Iodine Residue in Milk
1984
Phase III Multinational, Randomized, Double-Blind, Placebo-Controlled Study of Tivantinib (ARQ 197) Plus Erlotinib Versus Erlotinib Alone in Previously Treated Patients With Locally Advanced or Metastatic Nonsquamous Non–Small-Cell Lung Cancer
2015
Phase II study of eribulin mesylate (E7389) halichondrin b analog in patients with refractory breast cancer
2007
Phase II Study of the Halichondrin B Analog Eribulin Mesylate in Patients With Locally Advanced or Metastatic Breast Cancer Previously Treated With an Anthracycline, a Taxane, and Capecitabine
2010